Large Cap

Baxter International Inc. (NYSE:BAX) is down 19.4% at $22.66 at the last check on Thursday. At around 11 a.m. EST, shares of the medical device company traded at $21.68—just shy of its 52-week low. Baxter reported a second-quarter adjusted EPS of 59 cents. That’s inline with the management...

A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp. (NYSE:MSFT) sent major tech-heavy indices to fresh record highs Thursday, capping a fourth consecutive month of gains for U.S. equities. By midday in New York, the S&P 500 rose 0.7% to break above 6,400, while the...

U.S. stocks just wrapped up another strong month of gains with record-breaking levels, but history warns that August could quickly flip the script on this summer rally. The MAGS ETF is trading at new record highs. See the chart here. The S&P 500, tracked by the Vanguard S&P 500 ETF (NYSE:...

Cigna Group (NYSE:CI) reported second-quarter 2025 revenue of $67.13 billion on Thursday, beating analyst estimates of $62.46 billion. Sales increased 11% year over year, primarily driven by Evernorth Health Services, and include growth of existing client relationships and strong specialty...

Carvana Co (NYSE:CVNA) shares rallied in early trading on Thursday, after the company reported on Wednesday positive second-quarter earnings. CVNA shares are getting near their 52-week high. Check the latest price here. The announcement came amid an exciting earnings season. Here are some key...

Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% year over year, beating the analyst consensus of $4.06. The company reported sales of $2.65 billion, up 7% year over year on a reported basis, 8% on constant...

AbbVie Inc. (NYSE:ABBV) reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus of $14.98 billion. Sales increased 6.6% on a reported basis or 6.5% on an operational basis. The company reported adjusted earnings of $2.97, up 12.1% year over year and missing the...

Wall Street's most powerful tech giants are rewriting the rules of market dominance. What Happened: The so-called Magnificent Seven tech giants surged to a record-breaking $19.4 trillion in combined market value Thursday morning. This latest surge is reshaping the very structure of the S&P 500—...

Bristol Myers Squibb & Co (NYSE:BMY) reported second-quarter 2025 revenues of $12.27 billion, beating the consensus of $11.31 billion, almost flat year over year. U.S. sales slipped 3% to $8.5 billion, while international revenues climbed 10% to $3.8 billion, representing an 8% increase...

CVS Health Corp (NYSE:CVS) stock is trading higher on Thursday after the company reported better-than-expected Q2 earnings and raised its annual guidance. The company reported second-quarter sales of $98.90 billion on Thursday, beating the consensus of $94.85 billion. Total revenues increased...

Sanofi SA (NASDAQ:SNY) reported second-quarter sales of $11.33 billion (€9.99 billion euros), narrowly missing the consensus of $11.53 billion. Sales increased 6% year over year, up 10.1% in constant currency, driven by growth in Immunology, pharmaceutical launches and Beyfortus. The French drug...

Eli Lilly and Co. (NYSE:LLY) released topline results from SURPASS-CVOT, a head-to-head Phase 3 cardiovascular outcomes trial comparing Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, to Trulicity (dulaglutide), a GLP-1 receptor agonist. In SURPASS-CVOT, Mounjaro achieved the primary...

Copper prices plunged nearly 20% on Wednesday after President Donald Trump surprised markets by excluding refined copper from a sweeping 50% import tariff, abruptly ending a months-long rally fueled by fears of broad trade restrictions. The White House confirmed the new tariffs, effective August 1...

Used car retailer, Carvana Co. (NYSE:CVNA), reported a strong second-quarter performance, fueled partly by the chaos and uncertainties surrounding President Donald Trump’s trade and tariff policies during the quarter. Check out the current price of CVNA stock here. What Happened: During...

Takeda Pharmaceutical Company Limited (NYSE:TAK) posted a strong first-quarter performance for 2025 on Wednesday, with a net profit of 124.2 billion Japanese yen (approximately $834.08 million), reflecting a notable 30.4% year-over-year increase. The company reported earnings per American...